Literature DB >> 17520344

Information recovery in cancer families: value for risk estimations.

Hassan Roudgari1, Lindsey F Masson, Neva E Haites.   

Abstract

BACKGROUND: Drawing an informative pedigree is fundamental in genetic counselling. It is very common for some parts of pedigrees to remain ambiguous because of the proband's inability to recall the past history of her/his family. Current age, date of birth, date of death and age of diagnosis are the commonest missing information in pedigrees.
METHODS: The Scottish Social Statistics website, National Statistics website and English language literature were used to model extrapolations. About 172 Grampian families and three high-risk Grampian families with complete information were chosen to evaluate the influence of extrapolations on models' performance. Differences between original data and extrapolated data were assessed by independent samples t-test.
RESULTS: Changes made by extrapolations in age- and cancer-related information were not statistically significant (P > 0.05) in comparison with original data, except for average age of diagnosis of breast cancer (P = 0.03). The differences made by extrapolations in estimated probabilities generated by probability assessment models were small and ignorable except that for Tyrer-Cuzick model for Grampian family 3.
CONCLUSION: Extrapolations based on National Health Statistics can scientifically cover missing information in a defined population with minimum effect on performance of probability assessment models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520344     DOI: 10.1007/s10689-007-9140-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  30 in total

1.  Familial risks of cancer.

Authors:  D Easton
Journal:  Eur J Cancer       Date:  1999-07       Impact factor: 9.162

2.  A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

Authors:  D G R Evans; D M Eccles; N Rahman; K Young; M Bulman; E Amir; A Shenton; A Howell; F Lalloo
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 3.  The evolution of the population-based cancer registry.

Authors:  Donald M Parkin
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

Review 4.  Hereditary ovarian cancer: molecular genetics and clinical implications.

Authors:  J Boyd; S C Rubin
Journal:  Gynecol Oncol       Date:  1997-02       Impact factor: 5.482

Review 5.  Models of genetic susceptibility to breast cancer.

Authors:  A C Antoniou; D F Easton
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

6.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

7.  Breast cancer risk assessment: use of complete pedigree information and the effect of misspecified ages at diagnosis of affected relatives.

Authors:  S Schmidt; H Becher; J Chang-Claude
Journal:  Hum Genet       Date:  1998-03       Impact factor: 4.132

8.  No difference in survival between sporadic, familial and hereditary prostate cancer.

Authors:  H Grönberg; L Damber; B Tavelin; J E Damber
Journal:  Br J Urol       Date:  1998-10

Review 9.  BRCA1 gene in breast cancer.

Authors:  Eliot M Rosen; Saijun Fan; Richard G Pestell; Itzhak D Goldberg
Journal:  J Cell Physiol       Date:  2003-07       Impact factor: 6.384

Review 10.  Inherited predisposition to prostate cancer.

Authors:  Bas A J Verhage; Lambertus A L M Kiemeney
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more
  1 in total

1.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Authors:  Hassan Roudgari; Zosia H Miedzybrodzka; Neva E Haites
Journal:  Fam Cancer       Date:  2007-12-21       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.